A comparison between Dark Agouti and Sprague-Dawley rats in their behaviour on the elevated plus-maze, open-field apparatus and activity meters, and their response to diazepam

Psychopharmacology

Volumn 159, Issue 2, 2002, Pages 188-195

  Mechan, Annis O ^a,c   Moran, Paula M ^b,c   Elliott, Martin J ^a,c   Young, Andrew M ^b,c   Joseph, Michael H ^b,c   Green, Richard A ^a,c  

^a DE MONTFORT UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF LEICESTER   (United Kingdom)

^c ASTRAZENECA   (United Kingdom)

Author keywords

Anxiety; CYP2D6 poor metaboliser phenotype; Dark Agouti rats; Diazepam; Elevated plus maze; Open field; Sprague Dawley rats

Indexed keywords

ANXIOLYTIC AGENT; DIAZEPAM;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANXIETY; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG RESPONSE; MALE; MAZE TEST; NONHUMAN; OPEN FIELD TEST; PRIORITY JOURNAL; RAT; RAT STRAIN; STRAIN DIFFERENCE; TASK PERFORMANCE; TRANQUILIZING ACTIVITY;

ANIMALS; ANTI-ANXIETY AGENTS; ANXIETY; BEHAVIOR, ANIMAL; DIAZEPAM; HANDLING (PSYCHOLOGY); MALE; MAZE LEARNING; MOTOR ACTIVITY; RATS; RATS, SPRAGUE-DAWLEY; SPECIES SPECIFICITY;

EID: 0036166805     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002130100902     Document Type: Article

References (29)

1. Animal modelling of human polymorphic drug oxidation - The metabolism of debrisoquine and phenacetin in rat inbred strains
2. 1A receptor density and 8-OH-DPAT-induced hypothermia: Blockade by drugs preventing 5-hydroxytryptamine depletion
3. Characteristics of open field behavior of Wistar and Sprague Dawley rats
4. Bufuralol 1-hydroxylase activity of the rat. Strain differences and effects of inhibitors
5. Chronic handling modifies the anxiolytic effect of diazepam in the elevated plus-maze
6. Effect of serotonergic lesion on "anxious" behaviour measured in the elevated plus-maze test in the rat
7. 5-HT loss in rat brain following 3,4-methylenedioxymethamphetamine (MDMA), p-chloroamphetamine and fenfluramine administration and effects of chlormethiazole and dizocilpine
8. The hyperthermic and neurotoxic effects of 'Ecstasy' (MDMA) and 3,4-methylenedioxyamphetamine (MDA) in the Dark Agouti (DA) rat, a model of the CYP2D6 poor metaboliser phenotype
9. In vivo evidence for free radical involvement in the degeneration of rat brain 5-HT following administration of MDMA ("ecstasy") and p-chloroamphetamine but not the degeneration following fenfluramine
10. Role of hyperthermia in the protective effect of clomethiazole against MDMA ("ecstasy")-induced neurodegeneration, comparison with the novel NMDA channel blocker AR-R15896AR
11. Ethopharmacological analysis of rat behavior on the elevated plus-maze
12. Inbred Roman high- and low-avoidance rats: Differences in anxiety, novelty-seeking, and shuttlebox behaviors
13. Modification of chlordiazepoxide's behavioural and neurochemical effects by handling and plus-maze experience
14. Risk assessment behaviour: Evaluation of utility in the study of 5-HT-related drugs in the rat elevated plus-maze test
15. 5-HT drugs in animal models of anxiety
16. Multiple serotonin mechanisms in animal models of anxiety: Environmental, emotional and cognitive factors
17. Escape-related behaviours in an unstable elevated and exposed environment I. A new behavioural model of extreme anxiety
18. Purification and characterisation of the rat liver microsomal P450 involved in the 4-hyroxylation of debrisoquine, a prototype for genetic variation in oxidative drug metabolism
19. Behavioural profiles of two Wistar rat lines selectively bred for high or low anxiety-related behaviour
20. The anxiogenic and anxiolytic-like effects of MDMA on mice in the elevated plus-maze: A comparison with amphetamine
21. An investigation of the long-tem effects of (±)-3,4-methylenedioxymethamphetamine (MDMA, ecstasy) on the behaviour of Dark Agouti rats in the elevated plus maze and open field
22. The relationship between the degree of neurodegeneration of rat brain 5-HT nerve terminals and the dose and frequency of administration of MDMA ('ecstasy')
23. Validation of open:closed arm entries in an elevated plus maze as a measure of anxiety in the rat
24. Anxiety, defence and the elevated plus-maze
25. Combination of open field and elevated plus maze: A suitable test battery to assess strain as well as treatment differences in rat behavior
26. A neurotoxic regimen of MDMA suppresses behavioral, thermal and neurochemical responses to subsequent MDMA administration
27. Hydroxylation of debrisoquine using perfused liver isolated from Sprague Dawley and DA rats: Comparison with in vivo results
28. Two independent behavioral dimensions in open field performance
29. Comparison of acute and chronic treatment of various serotonergic agents with those of diazepam and idazoxan in the elevated plus maze